Table 2.
PPR to immunosuppression in MDS
Patient's age, y + duration of RCTD, mo
.
.
.
DR15
-
patients
.
DR15
+
patients
.
PPR
.
> 57
> 71
Low (0%-40%)
≤ 57
≤ 71
High (41%-100%)
Patient's age, y + duration of RCTD, mo
.
.
.
DR15
-
patients
.
DR15
+
patients
.
PPR
.
> 57
> 71
Low (0%-40%)
≤ 57
≤ 71
High (41%-100%)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal